Skip to main content
SpringerLink
Log in

Letter to the editor

  • Published:
Advances in Therapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Violante-Ortiz R, Del-Rio-Navarro BE, Lara-Esqueda A, Perez P, Fanghanel G, Madero A, Berber A. Use of sibutramine in obese Hispanic adolescents.Adv Ther. 2005;22:642–649.

    PubMed  CAS  Google Scholar 

  2. Berkowitz RI, Wadden TA, Tershakovec AM, Cronquist Y. Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized, placebo-controlled trial.JAMA. 2003; 289:1805–1812.

    Article  PubMed  CAS  Google Scholar 

  3. Beaston P. Clinical Review for NDA 20-632, SE5-021. BPCA Executive Summary. Recommendation on Regulatory Action for Meridia (sibutramine hydrochloride). Public Electronic Record by David Orloff, posted on November 2, 2005. Web page available at: http://www.fda.gov/cder/foi/esum/2005/ 020632s021_sibutramine_hydrochloride_Clinical_ BPCA.pdf

  4. Yanovski JA, Yanovski SZ. Treatment of pediatric and adolescent obesity.JAMA. 2003;289:1851–1853.

    Article  PubMed  Google Scholar 

  5. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs.N Engl J Med. 2000;342:1887–1892.

    Article  PubMed  CAS  Google Scholar 

  6. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials.N Engl J Med. 2000;342:1878–1886.

    Article  PubMed  CAS  Google Scholar 

  7. Pocock SJ, Elbourne DR. Randomized trials or observational tribulations?N Engl J Med. 2000; 342:1907–1909.

    Article  PubMed  CAS  Google Scholar 

References

  1. Violante-Ortiz R, Del-Rio-Navarro BE, Lara-Esqueda A, et al. Use of sibutramine in obese Hispanic adolescents.Adv Ther. 2005;22:642–649.

    PubMed  CAS  Google Scholar 

  2. Berkowitz RI, Wadden TA, Tershakovec AM, Cronquist JL. Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial.JAMA. 2003;289:1805–1812.

    Article  PubMed  CAS  Google Scholar 

  3. Clinical Review for NDA 20-632, SE5-021. Available at: http://www.fda.gov/cder/foi/ esum/2005/020632s021_sibutramine_hydrochloride_Clinical_BPCA.pdf. Accessed June 6, 2006.

  4. Patten SB. Major depressive episodes and diet pills.Exp Opin Pharmacother. 2002;3:1405–1409.

    Article  CAS  Google Scholar 

  5. García-Morales LM, Berber A, Macias-Lara CC, Lucio-Ortiz C, Del-Rio-Navarro BE, Dorantes-Alvárez LM. Use of sibutramine in obese Mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.Clin Ther. 2006;28:770–782.

    Article  PubMed  CAS  Google Scholar 

  6. Godoy-Matos A, Carraro L, Vieira A, et al. Treatment of obese adolescents with sibutramine: a randomized, double-blind, controlled study.J Clin Endocrinol Metab. 2005;90:1460–1465.

    Article  PubMed  CAS  Google Scholar 

  7. Del-Rio-Navarro BE, Velazquez-Monroy O, Sanchez-Castillo CP, et al, for Encuesta Nacional de Salud 2000 Working Group. National Health Survey 2000. The high prevalence of overweight and obesity in Mexican children.Obes Res. 2004; 12:215–223.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Genetics, Southwest Foundation for Biomedical Research, San Antonio, Texas, USA

    Raul A. Bastarrachea MD & Juan C. López-Alvarenga MD, PhD

  2. Endocrinology Unit, National Institute of Pediatrics, Mexico City, Mexico

    Raúl Calzada-León MD

  3. Endocrinology Unit, General Hospital of Mexico, Mexico City, Mexico

    Sara Arellano-Montaño MD

  4. Children’s Hospital of Mexico “Dr. Federico Gómez”, Mexico City, Mexico

    Jorge Gonzalez-Barranco MD

  5. Research Unit, Regional General Hospital No 6, Mexican Institute of Social Security, Madero City, Tamaulipas, Mexico

    Rafael Violante-Ortíz MD

  6. Children’s Hospital of Mexico “Federico Gomez”, Mexico City, D.F. Mexico

    Blanca Estela Del-Rio-Navarro MD

  7. Direction for the Adult and Elderly Health Program Ministry of Health, National Centre for Epidemiological Vigilance, Mexico City, D.F. Mexico

    Agustín Lara-Esqueda MD

  8. Cemain Hospital, Tampico, Tamaulipas, Mexico

    Pedro Pérez MD

  9. Cardiovascular Risk Factor Unit General Hospital of Mexico and Medicine Faculty, National Autonomous University of Mexico, Mexico City, D.F. Mexico

    Guillermo Fanghänel MD

  10. High Specialty Medicine Unit, Specialty Hospital No 71 Mexican Institute of Social Security, Torreon, Coahuila, Mexico

    Agustín Madero MD

  11. Research Unit, Regional General Hospital No 6 Mexican Institute of Social Security, Madero City, Tamaulipas, Mexico

    Arturo Berber MD, PhD

Authors
  1. Raul A. Bastarrachea MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Juan C. López-Alvarenga MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Raúl Calzada-León MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sara Arellano-Montaño MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jorge Gonzalez-Barranco MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rafael Violante-Ortíz MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Blanca Estela Del-Rio-Navarro MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Agustín Lara-Esqueda MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Pedro Pérez MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Guillermo Fanghänel MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Agustín Madero MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Arturo Berber MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bastarrachea, R.A., López-Alvarenga, J.C., Calzada-León, R. et al. Letter to the editor. Adv Therapy 23, 506–509 (2006). https://doi.org/10.1007/BF02850173

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02850173

Keywords

Search

Navigation